US2010247648A1PendingUtilityA1

Antimicrobial compounds

Assignee: NEOBIOTICS ABPriority: Nov 10, 2004Filed: Mar 8, 2010Published: Sep 30, 2010
Est. expiryNov 10, 2024(expired)· nominal 20-yr term from priority
A61P 31/18A61P 31/10A61P 31/20C07K 5/06095A61P 31/04A61P 31/16A61P 31/14A61P 31/22A61K 38/00Y02A50/30
31
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention relates to compositions comprising a compound based on the general formula (I) R 1 -Arg-R 2 —NH—CH(R 3 )—CH 2 —NH—R 4   (I) The composition may be used to eliminate and/or reduce microorganisms such as bacteria, viruses, fungi and protozoa.

Claims

exact text as granted — not AI-modified
1 . A method for treating viral, fungal, or a mixture of viral and bacterial infection or disease, the method comprising administering an effective amount of a medicament comprising a compound having the formula (I)
   R 1 -Arg-R 2 —NH—CH(R 3 )—CH 2 —NH—R 4      wherein   R 1  is benzyloxycarbonyl or 3-phenylpropionyl,   and   R 2  is an amino acid residue selected from the group consisting of Val, Ile, Leu and Phe,   and   R 3  is selected from the group consisting of isopropyl, isobutyl, sec.butyl, benzyl, 4-hydroxybenzyl and phenyl   and   R 4  is an acyl residue comprising a phenyl ring.   
   
   
       2 . A method according to  claim 1 , wherein the a compound is selected from the group consisting of: 
     
       
         
         
             
             
         
       
       
         
         
             
             
         
       
     
   
   
       3 . A method according to  claim 1 , wherein the virus is selected from the group consisting of polio viruses, Echoviruses, Herpesviridae, H5N1, SARS, HIV, adenoviruses, coxsackieviruses, hepatite A, B and C and rhinoviruses. 
   
   
       4 . A method according to  claim 1 , wherein said fungus is selected from the group consisting of candida, dermatophytes, and mould. 
   
   
       5 . A method according to  claim 1 , wherein said bacteria is selected from the group consisting of Staphylococci, Pneumococci, Streptococci, and  Listeria.    
   
   
       6 . A method according to  claim 1 , wherein the medicament further comprises one or more antimicrobial agents. 
   
   
       7 . A method according to  claim 1 , wherein the therapeutic agents are selected from the group consisting of penicillins, cephalosporins, carbacephems, cephamycins, carbapenems, monobactams, aminoglycosides, glycopeptides, quinolones, tetracyclines, macrolides, fluoroquinolones, antiseptic agents including iodine, silver, copper, chlorhexidine, polyhexanide and other biguanides, docosanol, acetic acid, and hydrogen peroxide. 
   
   
       8 . A method according to  claim 1 , wherein the medicament is in the form of granules, powders, tablets, coated tablets, (micro) capsules, suppositories, syrups, emulsions, gels, ointments, suspensions, creams, aerosols, drops or injectable solution in ampule form.

Join the waitlist — get patent alerts

Track US2010247648A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.